Overview
Portfolio
More
Gaozhangcap
Invests in early‑stage, content‑focused businesses at the intersection of content, commerce and technology, guided by the “Rich & Fun” credo.
Portfolio
14+
Employees
5+
Founded
2015
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedSources
Gaozhangcap
Invests in early‑stage, content‑focused businesses at the intersection of content, commerce and technology, guided by the “Rich & Fun” credo.
Portfolio
14+
Employees
5+
Founded
2015
AUM
N/A
Showing 14 of 14 matched portfolio companies
Ben is a unified platform that facilitates the learning, trading, and secure storage of cryptocurrency through a user-friendly interface. It addresses the challenges of fragmented access and security in the cryptocurrency market, enabling users to manage their digital assets efficiently.
Gen+ is a digital platform that provides leadership and meta-skills education for learners aged 9-14 and their teachers, utilizing a blended learning approach that combines online and in-person instruction. The program addresses the lack of standardized skills development in schools by equipping students with essential, transferable skills necessary for success in learning, work, and life.
Funding: $100.7K
Rough estimate of the amount of funding raised
Funding: $100.7K
Rough estimate of the amount of funding raised
The startup develops targeted therapies for cancer treatment through drug discovery focused on tumor immunology. By enhancing the immune response against tumors, the company aims to improve the quality of life for cancer patients.
Funding: $20.0M
Rough estimate of the amount of funding raised
Funding: $20.0M
Rough estimate of the amount of funding raised
IAN Intelligent Agent Network utilizes a decentralized Layer 2 infrastructure to integrate multiple AI agents, providing unbiased insights and enhancing trust through its Trust Engine, which scores Focus and Consistency. This approach addresses the issues of disinformation and bias in AI models, ensuring secure and transparent decision-making for businesses and individuals.
Lü offers an interactive audiovisual system that turns any wall in a gym, classroom, or community hall into a high‑definition, touch‑responsive canvas for active learning. Combining ceiling‑mounted projectors, motion‑sensing cameras, lighting, and spatial audio, the platform delivers 45+ curriculum‑aligned apps and customizable content for 5‑12‑year‑olds, supporting 25‑50+ children simultaneously. Schools and recreation centers can purchase the hardware outright and add a Lü+ subscription for premium apps and ongoing content updates.
Funding: $50.0K
Rough estimate of the amount of funding raised
Funding: $50.0K
Rough estimate of the amount of funding raised
Luo provides a platform for African businesses to convert XOF into USD or EUR and execute international payments within 48 hours, ensuring zero transaction fees and competitive exchange rates. This service addresses the challenge of slow and costly cross-border payments, enabling efficient supplier transactions for businesses in Senegal and Côte d'Ivoire.
Nu Quantum is developing the Entanglement Fabric, a networking architecture that integrates Quantum Processing Units through a Qubit-Photon Interface to create scalable, entangled qubit networks. This technology enables datacentre-scale quantum computing by facilitating modular hardware and software scaling, addressing the need for significantly more powerful quantum compute systems.
Funding: $19.9M
Rough estimate of the amount of funding raised
Funding: $19.9M
Rough estimate of the amount of funding raised
Re is an on‑chain reinsurance protocol that tokenizes real reinsurance treaties, issuing fully collateralized tokens backed by verified insurance premiums. The platform provides institutional investors and insurers with regulated, transparent access to the $800B+ reinsurance market, delivering 8‑16% annual yields that are largely uncorrelated with traditional assets while maintaining defined risk limits and underwriting discipline.
Funding: $7.0M
Rough estimate of the amount of funding raised
Funding: $7.0M
Rough estimate of the amount of funding raised
TON is a decentralized blockchain platform that enables users to conduct commission-free cryptocurrency transactions directly through Telegram, utilizing its native Toncoin for network operations and digital asset management. The platform addresses the need for secure and efficient peer-to-peer crypto transfers while providing easy access to decentralized applications and services.
Funding: $54.0M
Rough estimate of the amount of funding raised
Funding: $54.0M
Rough estimate of the amount of funding raised
Provides a digital platform that streamlines the leave of absence process for enterprise employers, replacing outdated manual systems with a personalized, mobile-friendly SaaS solution. This reduces HR support requests, improves employee and manager coordination, and ensures business continuity by preparing teams for key personnel absences.
Provides a mobile-first platform that allows users to create and share personalized digital spaces, or "verses," reflecting their interests, such as music, art, and lifestyle. This tool addresses the need for self-expression and curation in the digital age by combining user-generated content with customizable templates, enabling seamless sharing across social media and personal networks.
Funding: $500.0K
Rough estimate of the amount of funding raised
Funding: $500.0K
Rough estimate of the amount of funding raised
YAN provides a unified digital platform combining banking services with an e-commerce marketplace and bill payment features. Through a single "Super App," users can manage finances, shop for goods and services, and pay bills in one integrated ecosystem.
Yua connects retailers directly with manufacturers, eliminating intermediaries like wholesalers and super stockists in the glass supply chain. This approach reduces costs and improves product availability for retailers, enhancing their access to high-quality glass products.
Physios Biotech develops microphysiological systems (MPS) that replicate human organ functions and rare disease environments, utilizing advanced nanotechnology for high human extrapolation. Their technology reduces reliance on animal testing and accelerates drug development timelines by providing accurate safety evaluations and therapeutic assessments for rare cancers.